Purpose: Functional gastrointestinal disorders (FGIDs), such as irritable bowel syndrome (IBS), functional dyspepsia, and functional constipation, are among the most prevalent digestive conditions worldwide. Characterized by chronic symptoms without identifiable structural abnormalities, FGIDs drive sustained demand for symptom-based management, lifestyle interventions, and integrative care solutions.
Upload here: https://gastroenterology-hepatology.utilitarianevents.com/upload-presentation/
WhatsApp: https://wa.me/+971551792927
Email: info-ucg@utilitarianconferences.com
Keynote Points:
High global prevalence and chronic nature of FGIDs
Strong demand for symptom-relief therapies and OTC products
Growth of gut–brain axis–based and psychogastroenterology solutions
Opportunities in probiotics, dietary therapy, and medical nutrition
Rising adoption of digital therapeutics and remote symptom management
Increasing focus on patient education and lifestyle modification
Multidisciplinary care models gaining commercial traction
Benefits:
Large and recurring patient base ensuring long-term revenue streams
High ROI potential through OTC, prescription, and wellness products
Strong brand loyalty driven by chronic symptom management needs
Opportunities for cross-sector collaboration (pharma, nutrition, digital health)
Scalability via digital platforms, clinics, and consumer health channels
Alignment with preventive, holistic, and value-based healthcare trends